Dr Manish Aggarwal Clinic Logo
HomeAbout UsContact Us

Unexplained Weight Loss & Chest Pain? Understanding Non-Small Cell Lung Carcinoma

Do you have a persistent cough, unexplained weight loss, or chest pain that isn't going away? This could be Non-Small Cell Lung Carcinoma (NSCLC), the most common type of lung cancer. With early diagnosis and the right treatment from an experienced Non-Small Cell Lung Carcinoma Specialist, many patients achieve good outcomes, especially when it's caught early.

Oncology Overview

What Is Non-Small Cell Lung Carcinoma?

Non-Small Cell Lung Carcinoma is a type of lung cancer that develops when cells in the lung tissue grow abnormally and form a tumour. It accounts for the large majority of all lung cancer cases and grows and spreads more slowly than the other main type, small cell lung cancer, which generally gives a wider window for effective treatment.

NSCLC includes a few subtypes, such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, each behaving slightly differently. Without proper evaluation and treatment from a Non-Small Cell Lung Carcinoma Specialist, the cancer can spread to other parts of the body over time.

Pulmonary Oncology and Molecular Tissue Diagnostics
Clinical Presentation

Symptoms of Non-Small Cell Lung Carcinoma

NSCLC symptoms can be subtle in the early stages and are often mistaken for other respiratory conditions. Common signs include:

  • A persistent cough that doesn't go away or worsens over time
  • Coughing up blood or blood-tinged mucus
  • Chest pain that worsens with deep breathing, coughing, or laughing
  • Shortness of breath
  • Unexplained weight loss and loss of appetite
  • Hoarseness of voice
  • Recurrent infections like bronchitis or pneumonia
  • Fatigue and general weakness
Risk Matrices

Causes and Risk Factors

NSCLC develops due to changes in lung cells that lead to uncontrolled growth. Common causes and risk factors include:

  • Smoking : The leading risk factor, responsible for the majority of NSCLC cases.

  • Secondhand Smoke Exposure : Increases risk even in non-smokers.

  • Air Pollution : Long-term exposure to polluted air and vehicle exhaust.

  • Occupational Exposure : Exposure to asbestos, radon, and certain industrial chemicals.

  • Family History : A genetic predisposition can increase risk in some patients.

  • Prior Radiation Therapy : Previous radiation to the chest for another condition.

Investigative Protocol

Diagnostic Tests for Non-Small Cell Lung Carcinoma

Confirming NSCLC and identifying its exact type and stage is essential for building the right treatment plan. Dr. Manish Aggarwal uses the following tests:

  • Chest X-ray or CT scan
  • PET-CT scan to check the extent of spread
  • Bronchoscopy with Transbronchial Lung Biopsy to sample tissue
  • EBUS (Endobronchial Ultrasound) to examine nearby lymph nodes
  • Biopsy for tissue and molecular testing
  • Pulmonary Function Test (PFT) to assess lung capacity before treatment
Therapeutic Framework

Non-Small Cell Lung Carcinoma Treatment

Non-small cell lung carcinoma is the most common form of lung cancer, and treatment decisions depend heavily on how early it's caught and what makes the individual tumour tick. Dr. Manish Aggarwal builds each treatment plan around the cancer's stage, its specific subtype, and the patient's overall fitness for treatment, since these factors determine whether surgery is possible or whether other approaches take priority.

For early-stage disease, surgery often offers the best chance at removing the cancer entirely, while more advanced or inoperable cases rely on chemotherapy, radiation, targeted therapy, or immunotherapy, sometimes in combination, based on molecular testing and how the tumour behaves. Since NSCLC treatment often combines more than one approach, regular monitoring by your Non-Small Cell Lung Carcinoma Specialist helps track response and adjust the plan as needed.

Get a Treatment Plan Made for You

Every case of NSCLC is different, and so is the right treatment for it by Dr. Manish Aggarwal, your trusted Non-Small Cell Lung Carcinoma Specialist in Delhi.

Lead Pulmonologist

About Dr. Manish Aggarwal – Lung Cancer Specialist

Dr. Manish Aggarwal is a pulmonologist with years of experience diagnosing and managing lung cancer, including Non-Small Cell Lung Carcinoma. He completed his MBBS and MD in Tuberculosis and Chest Diseases from Delhi University, followed by NHS clinical experience in the United Kingdom and the prestigious FRCP (Glasgow) from the Royal College of Physicians.

He is known for explaining conditions in simple, easy-to-understand language and building treatment plans around each patient's specific test results and stage of disease, rather than offering a one-size-fits-all approach.

Find your Query here

Frequently Asked Questions

Non-small cell lung cancer can be curable, especially when it's diagnosed at an early stage and treated with surgery, sometimes combined with chemotherapy or radiation. In more advanced stages, treatment focuses on controlling the cancer's growth and managing symptoms, though outcomes vary depending on the subtype and how far it has spread.

Prognosis depends largely on the stage at diagnosis, the specific subtype, and how well the patient responds to treatment. Early-stage NSCLC generally has a better outlook than cancer that has spread to other organs. Molecular testing can also reveal targeted treatment options that improve outcomes for certain patients. A Non-Small Cell Lung Carcinoma Specialist can give a more personalised outlook after reviewing your specific test results.

Treatment depends on the stage and subtype of the cancer, and usually involves a combination of surgery, chemotherapy, radiation therapy, targeted therapy, or immunotherapy. Dr. Manish Aggarwal decides the right combination based on detailed imaging, biopsy results, and molecular testing.

Non-small cell lung carcinoma is the most common type of lung cancer, making up the large majority of cases. It includes subtypes like adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, and tends to grow and spread more slowly than small cell lung cancer, the other main type.

NSCLC is generally staged from I to IV, based on the size of the tumour and whether it has spread to lymph nodes or other parts of the body. Stage I is localised to the lung, while Stage IV indicates the cancer has spread to distant organs. Staging plays a major role in deciding the treatment approach.

Yes, a cough that lasts more than a few weeks, especially if accompanied by weight loss, blood in the mucus, or chest pain, should be evaluated by a pulmonologist. Early evaluation allows for timely diagnosis, which significantly improves treatment outcomes for lung cancer.

Still have questions?

We are available to answer queries, schedule urgent EBUS sessions or arrange Sleep diagnostic devices.

Contact Specialist Clinic

Your Path to the Right Treatment Starts Here

Early diagnosis can make all the difference. Get an expert evaluation and a personalised NSCLC treatment plan from Dr. Manish Aggarwal, your trusted Non-Small Cell Lung Carcinoma Specialist in Delhi.

1